1. Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor. Issue 10 (2nd October 2016) Authors: Assal, Amer; Dong, Baoxia; Khan, Hina; Medavarapu, Ramadevi; Shastri, Aditi; Pradhan, Kith; Friedman, Ellen; Mantzaris, Ioannis; Janakiram, Murali; Battini, Ramakrishna; Kornblum, Noah; Yu, Yiting; Verma, Amit; Braunschweig, Ira; Derman, Olga Journal: Leukemia & lymphoma Issue: Volume 57:Issue 10(2016:Oct.) Page Start: 2452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗